FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to anticancer drugs for oral use. The proposed tool in the form of a tablet contains methyl ester of Nα-tert-butyloxycarbonyl-S-tetrahydropyranylcysteinyl-phenylalanyl-D-tryptophyl-Nε-benzyl-oxycarbonyl-lysyltreonine and auxiliary substances: starch, lactose, talc, magnesium stearate, magnesium carbonate and lemon acid, at a certain quantitative ratio.
EFFECT: composition of the product ensures good automatic dosing on any existing automatic line for the production of tablets, while the production technology excludes the granulation stage. The tool is convenient to use, since it contains the required dose of the active substance in a unit dosage form, it can be used on an outpatient basis. The low amount of lactose allows the drug to be used by patients with hypolactasia. The invention shows high biological activity, which is equivalent to the prototype.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING HORMONE-DEPENDENT TUMORS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2703533C1 |
AGENT ELICITING ANTITUMOR EFFECT | 2003 |
|
RU2254139C1 |
ANTITUMOR MEDICATION | 2007 |
|
RU2335284C1 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
ANTI-CANCER DRUG TOPOISOMERASE I INHIBITOR | 2022 |
|
RU2786727C1 |
AGENT FOR TREATING OESTROGEN-DEPENDENT CANCER | 2012 |
|
RU2510268C1 |
USING TETRANITROSYL COMPLEX OF IRON WITH THIOPHENOL AS ANTI-TUMOUR MEDICINAL AGENT | 2007 |
|
RU2429242C2 |
METHOD FOR PRODUCING AMINO ACID ANALOGUES OF THE ANTITUMOUR ANTIBIOTIC REBECCAMYCIN | 2020 |
|
RU2755572C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
Authors
Dates
2021-06-02—Published
2020-08-06—Filed